News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Foamix To Present At The 34th Annual Cowen and Company Health Care Conference -- Successful Phase 2 For First Ever Topical Minocycline For Acne And Impetigo


2/27/2014 9:15:05 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

REHOVOT, Israel, Feb. 27, 2014 (GLOBE NEWSWIRE) -- Foamix, a clinical-stage, privately held specialty pharmaceutical company, focused on the development of proprietary topical foams for dermatology for itself and major pharmaceutical licensees, today announced that Dr. Dov Tamarkin, Chief Executive Officer, will speak at the Cowen & Company 34th Annual Health Care Conference, being held at the Boston Marriott Copley Place in Boston, Massachusetts, March 3-5, 2014. Dr. Tamarkin will provide an overview of the Company's business and commercial strategy. He will reveal successful results from Phase 2 Acne and Impetigo (including MRSA impetigo) clinical trials; and how the Company is transforming from a technology-based, licensing company into a commercial specialty pharmaceutical company.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES